Evaluation of Bone Mineral Density in Perimenopausal Period

Document Type: RESEARCH PAPER

Authors

1 Internal Medicine Department, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran Rheumatic Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Neurosurgery Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Internal Medicine Department, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran

4 Rosalind Franklin University of Medicine and Science, North Chicago,USA

Abstract

Background: The menopausal transition called perimenopause, happens after the reproductive years, and is
specified with irregular menstrual cycles, perimenopause symptoms and hormonal changes. Women going through
peri menopausal period are vulnerable to bone loss.
Osteoporosis is one of the most common debilitating metabolic bone diseases ,especially in the women almost
around 50 years .This study was intended to evaluate the prevalence of osteopenia/osteoporosis amongst
asymptomatic individuals during the menopause transition period.
Methods: A total of 714 asymptomatic peri-menopausal female volunteers were recruited through a billboard invitation
for participation in the study. The subjects were selected based on already defined inclusion and exclusion criteria.
The project, which was conducted between 2010 and 2014 was affiliated to the Educational and Therapeutic Center,
Imam Reza Hospital, Mashhad, Iran. Bone Mineral Densitometry (BMD) measured by DEXA (dual-energy X-ray
absorptiometry) was carried out on two distinct sites, the proximal femur and the lumbar vertebrae from L1 to L4.
Pertained data were analyzed.
Results: The mean age of the subjects was 49.7±2.years. The overall prevalence of osteopenia and osteoporosis
in these peri-menopausal individuals were 37.6 % and 10% respectively. Thirty five point two percent of 714 women
presented with osteopenia and eight percent of them have osteoporosis in the femoral neck, respectively. Nonetheless,
BMD values at the lumbar spine indicated 41.6% and 12% of individual participants being affected by osteopenia and
osteoporosis.
Conclusion: In general osteopenia or osteoporosis, occurred in 48% of this study population, implying that special
attention is required for the bone health status of Iranian women who undergo menopause.

Keywords

Main Subjects


1. Bromberger JT, Schott LL, Kravitz HM, Sowers M,
Avis NE, Gold EB, et al. Longitudinal change in
reproductive hormones and depressive symptoms
across the menopausal transition: results from
the Study of Women’s Health Across the Nation
(SWAN). Arch Gen Psychiatry. 2010; 67(6):598-
607.
2. Janiszewska M, Firlej E, Dziedzic M, Zolnierczuk-
Kieliszek D. Health beliefs and sense of one’s own
efficacy and prophylaxis of osteoporosis in peri- and
post-menopausal women. Ann Agric Environ Med.
2016; 23(1):167-73.
3. Van Voorhis BJ, Santoro N, Harlow S, Crawford
SL, Randolph J. The relationship of bleeding
patterns to daily reproductive hormones in women
approaching menopause. Obstet Gynecol. 2008;
112(1):101-8.
4. Castro JP, Joseph LA, Shin JJ, Arora SK, Nicasio J,
Shatzkes J, et al. Differential effect of obesity on
bone mineral density in White, Hispanic and African
American women: a cross sectional study. Nutr Metab.
2005; 2(1):9.
5. Khoury MJ. Genetic and epidemiologic approaches
to the search for gene-environment interaction:
the case of osteoporosis. Am J Epidemiol. 1998;
147(1):1-2.
6. Castrogiovanni P, Trovato FM, Szychlinska MA, Nsir
H, Imbesi R, Musumeci G. The importance of physical
activity in osteoporosis. From the molecular pathways
to the clinical evidence. Histol Histopathol. 2016;
31(11):1183-94.
7. Larijani B, Tehrani MR, Hamidi Z, Soltani A, Pajouhi M.
Osteoporosis, prevention, diagnosis and treatment. J
Reprod Infertil. 2005; 6(1):5-24.
8. Tsao LI. Relieving discomforts: the help‐seeking
experiences of Chinese perimenopausal women in
Taiwan. J Adv Nurs. 2002; 39(6):580-8.
9. Smeets-Goevaers CG, Lesusink GL, Papapoulos
SE, Maartens LW, Keyzer JJ, Weerdenburg JP, et
al. The prevalence of low bone mineral density
in Dutch perimenopausal women: the Eindhoven
perimenopausal osteoporosis study. Osteoporos Int.
1998; 8(5):404-9.
10. Shariat-Sarabi Z. Understanding osteoporosis aims
to boost our bone health. J Case Reports Pract. 2016;
4(3):19-21.
11. Akbarian M. Epidemiology and the importance of
osteoporosis Rheumatology Research Center. Tehran:
Andishmand, Tehran University of Medical Sciences;
2002.
12. Shirazi KK, Wallace LM, Niknami S, Hidarnia A,
Torkaman G, Gilchrist M, et al. A home-based,
transtheoretical change model designed strength
training intervention to increase exercise to prevent
osteoporosis in Iranian women aged 40-65 years: a
randomized controlled trial. Health Educ Res. 2007;
22(3):305-17.
13. Soltani A, Sedaghat M, Adibi H, Hamidi Z, Shenazandi
H, Khalilifar A, et al. Risk factor analysis of osteoporosis
in women referred to bone densitometry unit of
Endocrinology and Metabolism Research Center of
Tehran University of Medical Sciences. Iran South
Med J. 2002; 5(1):82-91.
14. Sharami SH, Milani F, Alizadeh A, Ranjbar ZA, Shakiba
M, Mohammadi A. Risk factors of osteoporosis in
women over 50 years of age: a population based study
in the north of Iran. J Turkish German Gynecol Assoc.
2008; 9(11):38-44.
15. Amiri M, Nabipour I, Larijani B, Beigi S, Assadi M,
Amiri Z, et al. The relationship of absolute poverty
and bone mineral density in postmenopausal
Iranian women. Int J Public Health. 2008; 53(6):
290-6.
16. Rowe SM, Jung ST, Lee JY. Epidemiology of
osteoporosis in Korea. Osteoporos Int. 1997; 7(Suppl
3):S88-90.
17. Sadat-Ali M, Al-Habdan IM, Al-Mulhim FA, El-Hassan
AY. Bone mineral density among postmenopausal
Saudi women. Saudi Med J. 2004; 25(11):1623-5.
18. Limpaphayom KK, Taechakraichana N, Jaisamrarn U,
Bunyavejchevin S, Chaikittisilpa S, Poshyachinda M, et
al. Prevalence of osteopenia and osteoporosis in Thai
women. Menopause. 2001; 8(1):65-9.
19. Larijani B, Hossein-Nezhad A, Mojtahedi A, Pajouhi
M, Bastanhagh MH, Soltani A, et al. Normative data of
bone Mineral Density in healthy population of Tehran,
Iran: a cross sectional study. BMC Musculoskelet
Disord. 2005; 6(1):38.
20. El-Desouki MI. Osteoporosis in postmenopausal Saudi
women using dual x-ray bone densitometry. Saudi
Med J. 2003; 24(9):953-6.
21. Cui LH, Choi JS, Shin MH, Kweon SS, Park KS, Lee
YH, et al. Prevalence of osteoporosis and reference
data for lumbar spine and hip bone mineral density
in a Korean population. J Bone Miner Metab. 2008;
26(6):609-17.
22. Guzman Ibarra M, Ablanedo Aguirre J, Armijo
Delgadillo R, Garcia Ruiz Esparza M. Prevalence
of osteopenia and osteoporosis assessed by
densitometry in postmenopausal women. Ginecol
Obstet Mex. 2003; 71(1):225-32.
23. D’Amelio P, Spertino E, Martino F, Isaia GC. Prevalence
of postmenopausal osteoporosis in Italy and
validation of decision rules for referring women
for bone densitometry. Calcif Tissue Int. 2013;
92(5):437-43.
24. Looker AC, Melton LJ 3rd, Harris TB, Borrud LG,
Shepherd JA. Prevalence and trends in low femur
bone density among older US adults: NHANES 2005-
2006 compared with NHANES III. J Bone Miner Res.2010; 25(1):64-71.

25. Brown JP, Fortier M, Frame H, Lalonde A,
Papaioannou A, Senikas V, et al. Canadian consensus
conference on osteoporosis, 2006 update. J Obstet
Gynaecol Can. 2006; 28(2 Suppl 1):S95-112.